Examining the Foundation of Patient Driven Medicine
Note: September is Pain Awareness Month
SACRAMENTO, Calif., Sept. 2 /PRNewswire-USNewswire/ -- Insurance companies are denying Fibromyalgia patients proper access to treatments for their chronic pain condition. Doctors are having a difficult time getting their fibromyalgia patients the appropriate therapies. While there are treatments available, including the FDA fast tracked prescription medicine Lyrica and now Cymbalta, there is a serious lack of access to treatments. Basically, insurance companies, including Medi-Cal, are denying access, or at least making it very difficult, for patients to get prescribed treatments. Fibromyalgia is a real condition but due to lack of awareness and validation, Fibromyalgia patients are forced to continue to suffer with the pain and doctors are unduly limited when there are options for treatment.
Below is more information. We hope you will consider taking a closer look at this concerning issue.
Denial letters, contact information for patients and doctors and other background information can be provided upon request.
Fibromyalgia is the most common chronic widespread pain condition in the United States. Studies indicate that at least 6 million Americans suffer from Fibromyalgia, but estimates range as high as 10 to 12 million people. Between 80-90 percent of people diagnosed with Fibromyalgia are women.
Yet, while many people are unaware of this condition or even question it, for those who suffer from it managing the pain can be extremely difficult. The recognition of the condition as a real disease is critical to opening options for treatment because the prognosis for people with Fibromyalgia has never been better.
See links below to websites with more information about Fibromyalgia.
About Treatments for Fibromyalgia and Access Issues
Broad, individualized therapeutic strategies can be
Copyright©2008 PR Newswire.
All rights reserved